# NCT02688036 (NCT02688036)

> Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLC

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02688036
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Conditions: Carcinoma, Small Cell; Lung Neoplasms
- Interventions: hypofractionated concurrent chemoradiotherapy; conventionally fractionated concurrent chemoradiotherapy
- Enrollment: 860
- Primary outcome: overall survival

## Indexed commentary on NCT02688036 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 3 posts on X

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=nct02688036